64 
References 
1. Design Criteria for Viral Oncology Research Facilities (1 975). 
U. S. Department of Health, Education, and Welfare, Public Health 
Service, National Institutes of Health; DHEW Publication No. (NIH) 
75-891. 
2. Kuehne, R. W. (1 973). Biological Containment Facility for Studying 
Infectious Disease. Appl. Microbiol. 26:239-2 43^ 
3. Runkle, R. S. , and G. B. Phillips (1969). Microbial Containment 
Control Facilities. Van Nostrand Reinhold, New YorlcT 
4. Chatigny, M.A., and D. I. Clinger (1 969). Contamination Control 
in Aerobiology . In An Introduction to Experimental Aerobiology, 
R. L. Dimmick and A. B. Akers (eds7")I John Wiley & Sons, 
New York, pp. 194-263. 
5. Leder, P. , D. Tiemier, and L. Enquist (1 977). EK2 Derivatives of 
Bacteriophage Lambda Useful in the Cloning of DNA from Higher 
Organisms: The Lambda gt WES~System. Sc lence 196:1 75 . 
6. Blattner, F. R. , et al. (1977). Charon Phages : Safer Derivatives 
of Bacte riophage Lambda for DNA Cloning. Science 1 96 :1 61 . 
7. Armstrong, K.A. , V. Hershfield, D. R. , and D. Helinski. Gene 
Cloning and Containment Properties of Plasmid ColEI and Its 
Derivatives. 
ii 
n 
8. Curtiss III, R. , et al. (in press). In Proceedings of the Tenth 
Miles International Symposium . Raven Press, New York. 
9. Grobstein, C. (1 977). The Recombinant-DNA Debate. Scientific 
American 237:22-33. 
Ji 
m 
